128 related articles for article (PubMed ID: 28543377)
1. Hepcidin levels and gastric cancer risk in the EPIC-EurGast study.
Jakszyn P; Fonseca-Nunes A; Lujan-Barroso L; Aranda N; Tous M; Arija V; Cross A; Bueno-de-Mesquita HBA; Weiderpass E; Kühn T; Kaaks R; Sjöberg K; Ohlsson B; Tumino R; Palli D; Ricceri F; Fasanelli F; Krogh V; Mattiello A; Jenab M; Gunter M; Perez-Cornago A; Khaw KT; Tjønneland A; Olsen A; Overvad K; Trichopoulou A; Peppa E; Vasilopoulou E; Boeing H; Sánchez-Cantalejo E; Huerta JM; Dorronsoro M; Barricarte A; Quirós JM; Peeters PH; Agudo A
Int J Cancer; 2017 Sep; 141(5):945-951. PubMed ID: 28543377
[TBL] [Abstract][Full Text] [Related]
2. Body iron status and gastric cancer risk in the EURGAST study.
Fonseca-Nunes A; Agudo A; Aranda N; Arija V; Cross AJ; Molina E; Sanchez MJ; Bueno-de-Mesquita HB; Siersema P; Weiderpass E; Krogh V; Mattiello A; Tumino R; Saieva C; Naccarati A; Ohlsson B; Sjöberg K; Boutron-Ruault MC; Cadeau C; Fagherazzi G; Boeing H; Steffen A; Kühn T; Katzke V; Tjønneland A; Olsen A; Khaw KT; Wareham N; Key T; Lu Y; Riboli E; Peeters PH; Gavrila D; Dorronsoro M; Quirós JR; Barricarte A; Jenab M; Zamora-Ros R; Freisling H; Trichopoulou A; Lagiou P; Bamia C; Jakszyn P
Int J Cancer; 2015 Dec; 137(12):2904-14. PubMed ID: 26135329
[TBL] [Abstract][Full Text] [Related]
3. Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
Chajès V; Jenab M; Romieu I; Ferrari P; Dahm CC; Overvad K; Egeberg R; Tjønneland A; Clavel-Chapelon F; Boutron-Ruault MC; Engel P; Teucher B; Kaaks R; Floegel A; Boeing H; Trichopoulou A; Dilis V; Karapetyan T; Mattiello A; Tumino R; Grioni S; Palli D; Vineis P; Bueno-de-Mesquita HB; Numans ME; Peeters PH; Lund E; Navarro C; Quirós JR; Sánchez-Cantalejo E; Gurrea AB; Dorronsoro M; Regnér S; Sonestedt E; Wirfält E; Khaw KT; Wareham N; Allen NE; Crowe FL; Rinaldi S; Slimani N; Carneiro F; Riboli E; González CA
Am J Clin Nutr; 2011 Nov; 94(5):1304-13. PubMed ID: 21993438
[TBL] [Abstract][Full Text] [Related]
4. Circulating Iron Levels Interaction with Central Obesity on the Risk of Nonalcoholic Fatty Liver Disease: A Case-Control Study in Southeast China.
Pan X; Chen B; Liu W; Li Y; Hu Z; Lin X; Xu S; Peng XE
Ann Nutr Metab; 2019; 74(3):207-214. PubMed ID: 30870854
[TBL] [Abstract][Full Text] [Related]
5. Serum Hepcidin in Children with Inflammatory Bowel Disease.
Krawiec P; Mroczkowska-Juchkiewicz A; Pac-Kożuchowska E
Inflamm Bowel Dis; 2017 Dec; 23(12):2165-2171. PubMed ID: 28945637
[TBL] [Abstract][Full Text] [Related]
6. Inverse relationship of serum hepcidin levels with CD4 cell counts in HIV-infected patients selected from an Indonesian prospective cohort study.
Wisaksana R; de Mast Q; Alisjahbana B; Jusuf H; Sudjana P; Indrati AR; Sumantri R; Swinkels D; van Crevel R; van der Ven A
PLoS One; 2013; 8(11):e79904. PubMed ID: 24244576
[TBL] [Abstract][Full Text] [Related]
7. Standardized serum hepcidin values in Dutch children: Set point relative to body iron changes during childhood.
Donker AE; Galesloot TE; Laarakkers CM; Klaver SM; Bakkeren DL; Swinkels DW
Pediatr Blood Cancer; 2020 Mar; 67(3):e28038. PubMed ID: 31724793
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin and iron metabolism associated with cardiometabolic risk factors in children: A case-control study.
Zhu YN; He BT; Jing J; Ma J; Li XH; Yang WH; Jin Y; Chen YJ
Nutr Metab Cardiovasc Dis; 2016 Jun; 26(6):525-33. PubMed ID: 27139516
[TBL] [Abstract][Full Text] [Related]
9. Inadequate hepcidin serum concentrations predict incident type 2 diabetes mellitus.
Pechlaner R; Weiss G; Bansal S; Mayr M; Santer P; Pallhuber B; Notdurfter M; Bonora E; Willeit J; Kiechl S
Diabetes Metab Res Rev; 2016 Feb; 32(2):187-92. PubMed ID: 26378394
[TBL] [Abstract][Full Text] [Related]
10. Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency.
Brătescu LO; Bârsan L; Gârneaţă L; Stanciu A; Lipan M; Stancu SH; Mircescu G
Int Urol Nephrol; 2014 May; 46(5):1005-12. PubMed ID: 24800994
[TBL] [Abstract][Full Text] [Related]
11. Serum hepcidin is associated with presence of plaque in postmenopausal women of a general population.
Galesloot TE; Holewijn S; Kiemeney LA; de Graaf J; Vermeulen SH; Swinkels DW
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):446-56. PubMed ID: 24334869
[TBL] [Abstract][Full Text] [Related]
12. Elevated Hepcidin Is Part of a Complex Relation That Links Mortality with Iron Homeostasis and Anemia in Men and Women with HIV Infection.
Minchella PA; Armitage AE; Darboe B; Jallow MW; Drakesmith H; Jaye A; Prentice AM; McDermid JM
J Nutr; 2015 Jun; 145(6):1194-201. PubMed ID: 25904736
[TBL] [Abstract][Full Text] [Related]
13. Serum Hepcidin Levels in Childhood-Onset Ischemic Stroke: A Case-Control Study.
Azab SF; Akeel NE; Abdalhady MA; Elhewala AA; Ali ASA; Amin EK; Sarhan DT; Almalky MAA; Elhindawy EM; Salam MMA; Soliman AA; Abdellatif SH; Ismail SM; Elsamad NA; Hashem MIA; Aziz KA; Elazouni OMA; Arafat MS
Medicine (Baltimore); 2016 Mar; 95(9):e2921. PubMed ID: 26945394
[TBL] [Abstract][Full Text] [Related]
14. Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents.
Inomata S; Anan A; Yamauchi E; Yamauchi R; Kunimoto H; Takata K; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Irie M; Shakado S; Sohda T; Sakisaka S
Intern Med; 2019 Oct; 58(20):2915-2922. PubMed ID: 31243222
[TBL] [Abstract][Full Text] [Related]
15. Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
Jenab M; Riboli E; Ferrari P; Sabate J; Slimani N; Norat T; Friesen M; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Touvier M; Boeing H; Schulz M; Linseisen J; Nagel G; Trichopoulou A; Naska A; Oikonomou E; Krogh V; Panico S; Masala G; Sacerdote C; Tumino R; Peeters PH; Numans ME; Bueno-de-Mesquita HB; Büchner FL; Lund E; Pera G; Sanchez CN; Sánchez MJ; Arriola L; Barricarte A; Quirós JR; Hallmans G; Stenling R; Berglund G; Bingham S; Khaw KT; Key T; Allen N; Carneiro F; Mahlke U; Del Giudice G; Palli D; Kaaks R; Gonzalez CA
Carcinogenesis; 2006 Nov; 27(11):2250-7. PubMed ID: 16774936
[TBL] [Abstract][Full Text] [Related]
16. Serum hepcidin levels in patients with end-stage renal disease on hemodialysis.
Rubab Z; Amin H; Abbas K; Hussain S; Ullah MI; Mohsin S
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):19-25. PubMed ID: 25579711
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial.
Gaillard CA; Bock AH; Carrera F; Eckardt KU; Van Wyck DB; Bansal SS; Cronin M; Meier Y; Larroque S; Roger SD; Macdougall IC
PLoS One; 2016; 11(6):e0157063. PubMed ID: 27276035
[TBL] [Abstract][Full Text] [Related]
18. Associations between serum hepcidin, ferritin and Hb concentrations and type 2 diabetes risks in a Han Chinese population.
Guo X; Zhou D; An P; Wu Q; Wang H; Wu A; Mu M; Zhang D; Zhang Z; Wang H; He L; Liu Y; Wang F
Br J Nutr; 2013 Dec; 110(12):2180-5. PubMed ID: 23742704
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies.
Julián-Serrano S; Yuan F; Wheeler W; Benyamin B; Machiela MJ; Arslan AA; Beane-Freeman LE; Bracci PM; Duell EJ; Du M; Gallinger S; Giles GG; Goodman PJ; Kooperberg C; Marchand LL; Neale RE; Shu XO; Van Den Eeden SK; Visvanathan K; Zheng W; Albanes D; Andreotti G; Ardanaz E; Babic A; Berndt SI; Brais LK; Brennan P; Bueno-de-Mesquita B; Buring JE; Chanock SJ; Childs EJ; Chung CC; Fabiánová E; Foretová L; Fuchs CS; Gaziano JM; Gentiluomo M; Giovannucci EL; Goggins MG; Hackert T; Hartge P; Hassan MM; Holcátová I; Holly EA; Hung RI; Janout V; Kurtz RC; Lee IM; Malats N; McKean D; Milne RL; Newton CC; Oberg AL; Perdomo S; Peters U; Porta M; Rothman N; Schulze MB; Sesso HD; Silverman DT; Thompson IM; Wactawski-Wende J; Weiderpass E; Wenstzensen N; White E; Wilkens LR; Yu H; Zeleniuch-Jacquotte A; Zhong J; Kraft P; Li D; Campbell PT; Petersen GM; Wolpin BM; Risch HA; Amundadottir LT; Klein AP; Yu K; Stolzenberg-Solomon RZ
Am J Clin Nutr; 2021 Oct; 114(4):1408-1417. PubMed ID: 34258619
[TBL] [Abstract][Full Text] [Related]
20. Serum hepcidin levels are related to serum markers for iron metabolism and fibrosis stage in patients with chronic hepatitis B: A cross-sectional study.
Çam H; Yılmaz N
Arab J Gastroenterol; 2020 Jun; 21(2):85-90. PubMed ID: 32423859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
